Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

PayPoint inks deal to take cash deposits for Lloyds customers

(Sharecast News) - PayPoint announced a partnership with Lloyds Banking Group on Tuesday, to provide cash deposit services for Lloyds, Halifax and Bank of Scotland customers at more than 30,000 retail locations across the UK. The FTSE 250 payment network operator said the service, which would roll out from 26 August, would allow customers to pay in up to £300 per day in notes and coins, with funds credited to their accounts within minutes.

PayPoint said over 99.5% of the UK population lives within one mile of one of its outlets, which are typically open long hours, seven days a week.

The initiative was part of PayPoint's 'BankLocal' service, and marked the first time high street banks would use the platform.

It said access to cash and local banking remained key drivers of organic growth, and would contribute to its target of delivering £100m EBITDA this year and longer-term growth through to the 2028 financial year.

"Our leading retail network provides a vast range of essential services at the heart of communities across the UK, for everything from banking, utility, parcel, cash and government services," said chief executive Nick Wiles.

"The ability of Lloyds customers to make cash deposits into their accounts at over 30,000 PayPoint locations will deliver more convenience and access for customers close to where they live."

At 1228 BST, shares in PayPoint were down 0.55% at 722p, while those in Lloyds Banking Group were up 0.3% at 82.68p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.